Daily feed · SEC Form 4 filings
Insider buying in low-priced stocks — Sep 11, 2018
Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 7, 2018 PForm 4 → | Sep 10, 4:46 pm EDT | Adaptimmune Therapeutics PLCADAP | Peter J Barris10% Owner | 15,000,000 | $1.67 | $25,000,500 | 12,000,000 | — | plan? |
| Sep 7, 2018 PForm 4 → | Sep 10, 4:46 pm EDT | Adaptimmune Therapeutics PLCADAP | Forest Baskett10% Owner | 15,000,000 | $1.67 | $25,000,500 | 12,000,000 | — | plan? |
| Sep 7, 2018 PForm 4 → | Sep 10, 4:47 pm EDT | Adaptimmune Therapeutics PLCADAP | Anthony A. Florence Jr.10% Owner | 15,000,000 | $1.67 | $25,000,500 | 12,000,000 | — | plan? |
| Sep 7, 2018 PForm 4 → | Sep 10, 4:48 pm EDT | Adaptimmune Therapeutics PLCADAP | David M MottDirector, 10% Owner | 15,000,000 | $1.67 | $25,000,500 | 12,000,000 | — | plan? |
| Sep 7, 2018 PForm 4 → | Sep 10, 4:49 pm EDT | Adaptimmune Therapeutics PLCADAP | Scott D Sandell10% Owner | 15,000,000 | $1.67 | $25,000,500 | 12,000,000 | — | plan? |
| Sep 7, 2018 PForm 4 → | Sep 10, 4:49 pm EDT | Adaptimmune Therapeutics PLCADAP | Peter W. Sonsini10% Owner | 15,000,000 | $1.67 | $25,000,500 | 12,000,000 | — | plan? |
| Sep 7, 2018 PForm 4 → | Sep 10, 4:49 pm EDT | Adaptimmune Therapeutics PLCADAP | Ravi Viswanathan10% Owner | 15,000,000 | $1.67 | $25,000,500 | 12,000,000 | — | plan? |
| Sep 7, 2018 PForm 4 → | Sep 10, 4:47 pm EDT | Adaptimmune Therapeutics PLCADAP | Ali BehbahaniDirector | 12,000,000 | $1.67 | $20,000,400 | 12,000,000 | — | plan? |
| Sep 7, 2018 PForm 4 → | Sep 10, 4:45 pm EDT | Adaptimmune Therapeutics PLCADAP | New Enterprise Associates 14, L.P. +210% Owner | 3,000,000 | $1.67 | $5,000,100 | 82,978,668 | +3.75% | plan? |
| Sep 7, 2018 PForm 4 → | Sep 10, 4:45 pm EDT | Adaptimmune Therapeutics PLCADAP | M James Barrett10% Owner | 3,000,000 | $1.67 | $5,000,100 | 82,978,668 | +3.75% | plan? |
| Sep 7, 2018 PForm 4 → | Sep 10, 4:48 pm EDT | Adaptimmune Therapeutics PLCADAP | Patrick J Kerins10% Owner | 3,000,000 | $1.67 | $5,000,100 | 82,978,668 | +3.75% | plan? |
| Sep 6, 2018 PForm 4 → | Sep 10, 5:46 pm EDT | vTv Therapeutics Inc.VTVT | Ronald O Perelman10% Owner | 1,879,699 | $1.33 | $2,500,000 | 6,778,470 | +38.4% | plan? |
| Sep 10, 2018 PForm 4 → | Sep 10, 7:19 pm EDT | KINGSWAY FINANCIAL SERVICES INCKFS | Douglas LevineDirector | 101,900 | $2.42 | $246,681 | 1,054,786 | +10.7% | plan? |
| Sep 10, 2018 PForm 4 → | Sep 10, 7:32 pm EDT | KINGSWAY FINANCIAL SERVICES INCKFS | John Taylor Maloney FitzgeraldCEO and President, Director | 13,700 | $2.45 | $33,515 | 889,953 | +1.56% | plan? |
| Sep 10, 2018 PForm 4 → | Sep 10, 4:31 pm EDT | 180 DEGREE CAPITAL CORP. /NY/TURN | Kevin RendinoChairman and CEO, Director | 10,000 | $2.14 | $21,400 | 482,605 | +2.12% | plan? |
| Sep 10, 2018 PForm 4 → | Sep 11, 8:23 am EDT | Summer Infant, Inc.SUMR | Mark MessnerPresident and C.E.O., Director | 5,500 | $1.73 | $9,515 | 158,000 | +3.61% | plan? |
| Sep 7, 2018 PForm 4 → | Sep 11, 8:23 am EDT | Summer Infant, Inc.SUMR | An Evelyn DDirector | 2,850 | $1.75 | $4,988 | 25,350 | +12.7% | plan? |
| Sep 7, 2018 PForm 4 → | Sep 11, 12:47 pm EDT | NANOPHASE TECHNOLOGIES CorpNANX | R Janet WhitmoreDirector | 4,900 | $0.85 | $4,165 | 1,280,406 | +0.38% | plan? |
| Sep 6, 2018 PForm 4 → | Sep 10, 5:56 pm EDT | DIGIRAD CORPDRAD | CANNELL CAPITAL LLC10% Owner | 800 | $1.74 | $1,388 | 2,162,542 | +0.04% | plan? |
| Sep 7, 2018 PForm 4 → | Sep 11, 3:34 pm EDT | ENDONOVO THERAPEUTICS, INC.ENDV | Michael Scott MannPresident, 10% Owner | 15,600 | $0.0384 | $599 | 25,909,798 | +0.06% | plan? |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.